Global Fertility Drugs Market

Overview Of The Fertility Drugs Market 2023-2032: Growth And Major Players Analysis

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The worldwide fertility drugs market anticipates a 3.5% growth from $2.93 billion in 2022 to $3.03 billion in 2023. It’s projected to reach $3.30 billion by 2027, with a 2.1% CAGR.

North America held the largest fertility drugs market share, and Middle East was the fastest-growing region in 2022.

Fertility Drugs Market Driver
Increasing infertility rates worldwide drive demand for fertility drugs. Infertility, defined as unsuccessful conception after a year of trying, affects both genders. Factors include physiology, hormones, lifestyle, and the environment. Fertility drugs regulate ovulation in women. WHO reported millions of reproductive-age individuals facing infertility, impacting families and communities. Globally, 48 million couples and 186 million individuals experience infertility. Hence, growing global infertility cases boost fertility drug market growth.

View More On The Fertility Drugs Market Report 2023 –

Prominent Fertility Drugs Market Trend
Fertility drug companies prioritize self-administration solutions for advanced infertility treatment. These solutions simplify and ease daily injections for women. For instance, in August 2021, Merck Specialities in India introduced the Pergoveris Pen, enhancing convenience and precision for severe FSH and LH deficiency treatment. It combines freeze-dried powder and solvent to minimize reconstitution errors, making it more accessible for self-administration during infertility treatment.

Fertility Drugs Market Prominent Players
Major players in the fertility drugs market are Merck & Co., Ferring Pharmaceuticals, Bayer, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer, Novartis AG, Procter & Gamble Pharmaceutical, Zydus Pharma, LIVZON, Abbott, MSD, Sanofi S.A., Eli Lilly and Co., Serono, Inc., Novogyne Pharmaceuticals, and Takeda Pharmaceutical co. ltd.

Request A Sample Of The Global Fertility Drugs Market Report 2023:

Key Fertility Drugs Market Segments
The global fertility drugs market is segmented –
1) By Gender: Male, Female
2) By Route of Administration: Oral, Intravenous, Subcutaneous, Intramuscular
3) By Type Of Drug: Prescription Fertility Drugs, Over-The-Counter Fertility drugs
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

The Fertility Drugs Global Market Report 2023  provides a comprehensive overview on the fertility drugs market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Fertility Services Global Market Report 2023
Fertility Treatments Global Market Report 2023
Female Fertility And Pregnancy Rapid Test Global Market Report 2023

Contact us at:
The Business Research Company:
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
Global Market Model: